Placebo-controlled evaluation of three doses of a controlled-onset, extended-release formulation of verapamil in the treatment of stable angina pectoris
- 1 June 1995
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 75 (16) , 1102-1106
- https://doi.org/10.1016/s0002-9149(99)80738-3
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Sustained‐Release Verapamil Formulations for Treating HypertensionThe Journal of Clinical Pharmacology, 1992
- Comparative Efficacy, Safety and Pharmacokinetics of VErapamil SR vs VErapamil IR in Hypertensive PatientsDrugs, 1992
- Circadian rhythms in cardiovascular diseaseAmerican Heart Journal, 1990
- Effects of Antihypertensive Agents on Circadian Blood Pressure and Heart Rate PatternsArchives of internal medicine (1960), 1988
- Circadian variation in the incidence of sudden cardiac death in the framingham heart study populationThe American Journal of Cardiology, 1987
- Circadian rhythms and coronary artery diseaseThe American Journal of Cardiology, 1987
- Efficacy of sustained-release verapamil in chronic stable angina pectorisThe American Journal of Cardiology, 1987
- Circadian variation of transient myocardial ischemia in patients with coronary artery disease.Circulation, 1987
- The efficacy and safety of high-dose verapamil and diltiazem in the long-term treatment of stable exertional anginaClinical Cardiology, 1984
- Efficacy and safety of verapamil in patients with angina pectoris after 1 year of continuous, high-dose therapyThe American Journal of Cardiology, 1983